Top End hospital leads the green revolution in health care
A volunteer project at Royal Darwin Hospital (RDH) is using native landscapes to adapt to climate while enhancing wellbeing, Indigenous cultural security and local biodiversity.
Latest
Prevention of pregnancy complications should be a priority
Prevention of common pregnancy complications has the potential to improve maternal health, reduce long term metabolic and cardiovascular risk, decrease transgenerational transmission of future disease risk to babies, and reduce hospital costs.
Blood on their hands
A report into the UK’s infected blood scandal exposes shocking systemic failures.
Navigating gluten-related disorders: bridging gaps in understanding and management
Despite the increasing awareness and prevalence of gluten sensitivities and coeliac disease, significant gaps in understanding persist within the medical community.
Translating research into policy for oral health and chronic disease
Using research in policy development is a complex process in which policy makers encounter numerous barriers. An evidence-based process is essential to improve policy strategies on oral health and chronic disease.
A new approach to managing lung disease in children
Recent developments in the treatment of adult asthma could be adapted to treat suppurative lung disease and wheezing in children, according to new research from the Murdoch Children’s Research Institute.
Are digital mental health services cost-effective and safe?
In Part 2 of her series, Dr Louise Stone explores whether digital mental health services are providing the safety and value for money we expect.
Silicosis registry – a long time coming
After years of rising numbers of silicosis cases, a federal government taskforce, and tireless calls for action, a national registry has been launched for occupational respiratory diseases.
Federal government bans 'alarming' production of Ozempic replicas
The federal government will ban compounding pharmacies from producing replicas of popular diabetes and weight loss drug Ozempic (Novo Nordisk) following an investigation that found a compounding racket had marketed and sold illegal replicas of the drug in Australia and the United States.
